Centessa Pharmaceuticals plc (CNTA)
NASDAQ: CNTA · Real-Time Price · USD
16.90
-0.63 (-3.59%)
Dec 24, 2024, 1:00 PM EST - Market closed
Centessa Pharmaceuticals Analyst Ratings
Total Analysts
7
Consensus Rating
Strong Buy
Price Target
$23.71
Upside
+40.30%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Guggenheim | Guggenheim | Strong Buy Maintains $24 → $28 | Strong Buy | Maintains | $24 → $28 | +65.68% | Nov 15, 2024 |
| Morgan Stanley | Morgan Stanley | Hold → Buy Upgrades $11 → $26 | Hold → Buy | Upgrades | $11 → $26 | +53.85% | Sep 19, 2024 |
| B. Riley Securities | B. Riley Securities | Strong Buy Initiates $33 | Strong Buy | Initiates | $33 | +95.27% | Sep 19, 2024 |
| BMO Capital | BMO Capital | Buy Maintains $20 → $35 | Buy | Maintains | $20 → $35 | +107.10% | Sep 16, 2024 |
| Guggenheim | Guggenheim | Strong Buy Maintains $20 → $24 | Strong Buy | Maintains | $20 → $24 | +42.01% | Sep 11, 2024 |
| Jefferies | Jefferies | Strong Buy Maintains $13 → $19 | Strong Buy | Maintains | $13 → $19 | +12.43% | Sep 11, 2024 |
| BMO Capital | BMO Capital | Buy Maintains $15 → $20 | Buy | Maintains | $15 → $20 | +18.34% | Sep 9, 2024 |
| Oppenheimer | Oppenheimer | Buy Reiterates $14 | Buy | Reiterates | $14 | -17.16% | Aug 14, 2024 |
| Oppenheimer | Oppenheimer | Buy Initiates $14 | Buy | Initiates | $14 | -17.16% | Jul 18, 2024 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $8 → $11 | Hold | Maintains | $8 → $11 | -34.91% | Jun 21, 2024 |
| BMO Capital | BMO Capital | Buy Maintains $15 | Buy | Maintains | $15 | -11.24% | Apr 1, 2024 |
| Jefferies | Jefferies | Hold → Strong Buy Upgrades $4 → $11 | Hold → Strong Buy | Upgrades | $4 → $11 | -34.91% | Nov 15, 2023 |
| Morgan Stanley | Morgan Stanley | Sell → Hold Upgrades $4 → $8 | Sell → Hold | Upgrades | $4 → $8 | -52.66% | Oct 26, 2023 |
| SVB Securities | SVB Securities | Buy Maintains $6 → $11 | Buy | Maintains | $6 → $11 | -34.91% | Aug 15, 2023 |
| Guggenheim | Guggenheim | Strong Buy Maintains $9 → $10 | Strong Buy | Maintains | $9 → $10 | -40.83% | Aug 15, 2023 |
| Goldman Sachs | Goldman Sachs | Hold Maintains $4.5 → $5 | Hold | Maintains | $4.5 → $5 | -70.41% | Aug 15, 2023 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.